Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats

Journal of Nutrition

Volumn 126, Issue 12, 1996, Pages 3063-3068

  Masuda, Osamu ^a   Nakamura, Yasunori ^a   Takano, Toshiaki ^a  

^a Calpis Food Industry Co Ltd   (Japan)

Author keywords

angiotensin I converting enzyme; antihypertensive peptide; fermented milk; intestinal absorption; spontaneously hypertensive rats

Indexed keywords

AMINO ACID; CALPIS; DIPEPTIDYL CARBOXYPEPTIDASE; ISOLEUCYLPROLYLPROLINE; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG ABSORPTION; ENZYME INHIBITION; FOOD COMPOSITION; HYPERTENSION; MALE; MILK; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIDE ANALYSIS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030469762     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.12.3063     Document Type: Article

References (34)

1. Adibi, S. A. (1977) Clearance of dipeptide from plasma: role of kidney and intestine peptide transport hydrolysis. CIBA Found. Symp. 50: 265-285.
2. Chevillard, C., Brown, N. L., Mathieu, M., Laliberte, F. & Worcel, M. (1988) Differential effects of oral trondolapril and enalapril on rat tissue angiotensin-converting enzyme. Eur. J. Pharmacol. 147: 23-28.
3. Cohen, M. L., Wiley, K. S. & Kurz, K. K. (1983) Effect of acute oral administration of Captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat. Life Sci. 32: 565-569.
4. Cushman, D. W. & Cheung, H. S. (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20: 1637-1648.
5. Das, M. & Soffers, R. S. (1975) Pulmonary angiotensin-converting enzyme. J. Biol. Chem. 250: 6762-6768.
6. Erdos, E. G. (1975) Angiotensin I converting enzyme. Circ. Res. 36: 247-255.
7. Ganten, D., Schelling, P., Vecsei, P. & Ganten, U. (1976) Iso-renin of extrarenal origin: the tissue angiotensiogenase systems. Am. J. Med. 60: 760-772.
8. Giasson, S. D., Gutkowska, J., Garcia, R. & Genest, J. (1981) Renin substrate in rat mesenteric artery. J. Physiol. Pharmacol. 59: 528-532.
9. Hara, H., Funabiki, R., Iwata, M. & Yamazaki, K. (1984) Portal absorption of small peptides in rats under unrestrained conditions. J. Nutr. 114: 1122-1129.
10. Inada, Y., Terashita, Z., Imura, Y., Tanabe, M., Nishikawa, K. & Kikuchi, S. (1986) Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound. Jpn. J. Pharmacol. 42: 99-108.
11. Jarrott, B., Drummer, O., Hooper, R., Anderson, A. I., Miach, P. J. & Louis, W. J. (1982) Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects. Am. J. Cardiol. 49: 1547-1549.
12. Kim, S. Y., Bertwhistle, W. & Kim, Y. W. (1972) Peptide hydrolyses in the brush border and soluble fractions of small intestinal mucosa of rat and man. J. Clin. Invest. 51: 1419-1430.
13. Kripalani, K. J., McKinstry, D. N., Singhvi, S. M., Willard, D. A. & Vukovich, R. A. (1980) Disposition of captopril in normal subjects. Clin. Pharmacol. Ther. 27: 636-641.
14. Lowry, O. H., Rosebrogh, N. J., Fan, A. L. & Randoll, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
15. Maruyama, S., Miyoshi, S., Kaneko, T. & Tanaka, H. (1989) Angiotensin I-converting enzyme activities of synthetic peptides related to the tandem repeated sequence of a maize endosperm protein. Agric. Biol. Chem. 53: 1077-1081.
16. Maruyama, S., Nakagomi, K., Tomizuka, N. & Suzuki, H. (1985) Angiotensin-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and ileum of rats. Agric. Biol. Chem. 49: 1405-1409.
17. Matsui, T., Matsufuji, H., Seki, E., Osajima, K., Nakashima, M. & Osajima, Y. (1993) Inhibition of angiotensin I-converting enzyme by Bacillus licheniformis alkaline protease hydrolyzates derived from sardine muscle. Biosci. Biotech. Biochem. 57: 922-925.
18. Matthews, D. M. & Adibi, S. A. (1976) Peptide absorption. Gastroenterology 71: 151-161.
19. Miyazaki, M., Okunishi, H., Nishimura, K. & Toda, N. (1984) Vascular angiotensin-converting enzyme activity in man and other species. Clin. Sci. (Lond.) 66: 39-45.
20. Mock, L. W., Green, P. C. & Boyer, K. D. (1990) Specificity and pH dependence for acylproline cleavage by prolidase. J. Biol. Chem. 265: 19600-19605.
21. Nakamura, Y., Masuda, O. & Takano, T. (1996) Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk spontaneously to hypertensive rats. Biosci. Biotech. Biochem. 60: 488-489.
22. Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. & Takano, T. (1995a) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78: 777-783.
23. Nakamura, Y., Yamamoto, N., Sakai, K. & Takano, T. (1995b) Antihypertensive effects of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 78: 253-257.
24. Okunishi, H., Kawamoto, T., Kurobe, Y., Oka, Y., Ishi, K., Tanaka, T. & Miyazaki, M. (1991) Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Chin. Exp. Pharmacol. 18: 649-659.
25. Re, R., Fallon, J. T., Drau, U., Quay, S. C. & Haber, E. (1982) Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci. 30: 99-106.
26. Silk, D.B.A., Fairclough, P. D., Clark, M. L., Hegarty, J. E., Marrs, T. C., Addison, J. M., Burston, D., Clegg, K. M. & Matthews, D. M. (1980) Use of a peptide rather than free amino acid nitrogen source in chemically defined "elemental" diet. J. Parent. Enteral Nutr. 4: 548-553.
27. Skeggs, L. T., Kahn, J. K. & Shumway, N. P. (1956) The preparation and function of the angiotensin-converting enzyme. J. Exp. Med. 103: 295-299.
28. Steel, R.G.D. & Torrie, J. H. (1982) Principles and Procedures of Statistics: A Biometrical Approach. McGraw-Hill International Book Company, Auckland, New Zealand.
29. Unger, T. H., Ganten, D., Lang, R. E. & Schölkens, B. (1984) Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitor? Studies with the two different compounds, Hoe498 and MK421. J. Cardiovasc. Pharmacol. 6: 872-880.
30. Unger, T. H., Ganten, D., Lang, R. E. & Schölkens, B. (1985) Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 7: 36-41.
31. Unger, T. H., Kaufmann-Bühler, Schölkens, B. & Ganten, D. (1981) Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of Captopril in spontaneously hypertensive rats. Eur. J. Pharmacol. 70: 467-478.
32. Velletri, P. & Bean, B. L. (1982) The effects of Captopril on rat aortic angiotensin-converting enzyme. J. Cardiovasc. Pharmacol. 4: 315-325.
33. Yokokawa, K., Chiba, H. & Yoshikawa, M. (1992) Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci. Biotech. Biochem. 56: 1541-1545.
34. Yoshimoto, T., Fischl, M., Orlowski, R. C. & Walter, R. (1978) Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase comparison of two peptidases with high specificity for proline residues. J. Biol. Chem. 253: 3708-3716.